A niosome based topical gel of adapalene was developed and characterized for the treatment of mild acne. Adapalene is a thirdgeneration topical retinoid primarily used in the treatment of mild-moderate acne. Niosomes containing adapalene were prepared by lipid film hydration technique using nonionic surfactants (span 60) and cholesterol at different concentrations. All the niosomal formulations were evaluated for FTIR studies, entrapment efficiency, optical microscopy, stability studies, invitro drug release study, and zeta potential analysis. Then the optimized niosomal formulation was used for formulating topical gel consisting of carbopol 934. All the formulations were tested for physical properties, in-vitro drug release and skin irritation test. The result suggests that in all the prepared niosomal formulations as the surfactant concentration increases the entrapment efficiency increases. Lower the cholesterol concentration higher the entrapment efficiency in span 60 formulations. The size of niosomes was found to be uniform and spherical in shape. The entrapment efficiencies of all formulation were calculated. The IR spectral analysis suggested that there was no interaction between the drug and formulation excipients. The drug content was in the range of 95.04±0.57 to 90.68±0.39. The in-vitro release data was calculated using franz diffusion cell. The percentage drug release of all the formulations was in the range of 68.3 to 46.1. Korsmeyer peppas model indicated that the drug permeation from the niosomal gel followed diffusion and super case ІІ transport. The skin irritation results showed no specific irritation on the skin of rats. Niosomal gel of adapalene offer a promising avenue to fulfill the need for topical drug delivery system that can localize and maintain drug activity at the site of action for a longer period of time thus allowing a sustained action, minimizing frequency of drug administration with patient compliance.
Introduction
In recent years, vesicles have become the vehicle of choice in drug delivery. Lipid vesicles were found to be of value in immunology, membrane biology, diagnostic techniques and most recently, genetic engineering. Vesicles can play a major role in modeling biological membranes and in the transport and targeting of active agents [1] . Encapsulation of a drug in vesicular structures can be predicted to prolong the existence of the drug in systemic circulation and perhaps, reduces the toxicity if selective uptake can be achieved. The phagocytic uptake of the systemic delivery of drug loaded vesicular delivery system provides an efficient method for delivery of drug directly to the site of infection, leading to reduction of drug toxicity with no adverse effects. Vesicular drug delivery reduces the cost of therapy by improved bioavailability of medication, especially in case of poorly soluble drugs [2] . They can incorporate both hydrophilic and lipophilic drugs. These systems delay drug elimination of rapidly metabolizable drugs and function as sustained release systems and solve the problems of drug insolubility, instability and rapid degradation. Consequently, a number of vesicular delivery systems such as liposomes, transfersomes, pharmacosomes, niosomes etc, were developed [3] .
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Niosomes are non-ionic surfactant vesicles obtained by hydration of synthetic non-ionic surfactants, with or without incorporation of cholesterol or other lipids [4] . They are vesicular system that can be used to carry hydrophilic or hydrophobic drug. In niosomes, the vesicles forming amphiphile is a nonionic surfactant such as span 60 which is usually stabilized by addition of cholesterol and small amount of anionic surfactant such as dicetyl phosphate [5] . Niosomes can entrap both hydrophilic and lipophilic drugs, either in aqueous layer or in vesicular membrane made of lipid materials [6] . It is reported to attain better stability than liposomes [7] . It can prolong the circulation of the entrapped drugs. Because of the presence of nonionic surfactant with the lipid, there is better targeting of drugs to tumour, liver and brain. It may prove very useful for targeting the drug for treating cancers, parasitic, viral and other microbial disease more effectively.
The term "gels" is broad, encompassing semisolid of a wide range of characteristics from fairly rigid gelatin slabs, to suspensions of colloidal clays, to certain greases. A gel can be looked upon as being composed of two interpenetrating phase (the gelling agent and a fluid component). Gels are semisolid, being either suspensions of small inorganic particle or large organic molecule interpenetrated with liquid. In the first case, the inorganic particles, such as bentonite, form a three-dimensional "house of cards" structure throughout the gel. This is a true two-phase system, as the inorganic particles are not soluble but merely dispersed throughout the continuous phase [8] [9] [10] .
Adapalene is a third-generation topical retinoid primarily used in the treatment of mild-moderate acne. Mechanistically, adapalene binds to specific retinoic acid nuclear receptors (gamma and beta) and retinoid X receptors but does not bind to the cytosolic receptor protein. Although the exact mode of action of adapalene is unknown, it is suggested that topical adapalene may normalize the differentiation of follicular epithelial cells resulting in decreased microcomedone formation [11, 12] . With all the above aspects in mind the present work was aimed at investigating the potential of niosomal gel contain in adapalene as topical drug delivery systems for the treatment of acne vulgaris so asto increase the contact time of the drug with the skin, reduce the number of application and better patient compliance. So in this work an attempt has been made to provide noisome based transdermal drug delivery.
Materials and Methods

Materials
Adapalene was obtained from Systopic labs, Ahmadabad, India, as gift sample. Span 60 was obtained from CIDF, Cochin. Carbopol 934 was obtained from Thomas baker, Mumbai. Ethanol was obtained from Loba Chemie Pvt Ltd, Mumbai. Cholesterol was obtained from Merck India Ltd. DMSO were provided by Hi Media Ltd, Mumbai. All other solvents and reagents used for study were of analytical grade.
Methods
Preformulation study
The compatibility between pure drug and surfactants, cholesterol were detected by FTIR spectra.
Preparation of niosomes
The niosome formulations were prepared by lipid film hydration technique. Adapalene is soluble in DMSO. Nonionic surfactant and cholesterol were weighed and dissolved in proper ratio of chloroform and methanol (2:1) in a 100 ml round bottom flask. A thin lipid film was formed under reduced pressure in a rotary flash evaporator; temperature was maintained at 60 0 C or above. The film was then re hydrated by 10 ml of phosphate buffer saline pH 7.4 at a temperature above the glass transition temperature of the surfactant with gentle shaking. The niosome suspension obtained was sonicated for 5 min which forms small sized vesicles [13] [14] . (Table 1) Drug content used 10 mg per batch
Evaluation of niosomes
Microscopy
The vesicle formation by the particular procedure was confirmed by optical microscopy in 400x resolution. The noisome suspension placed over a glass slide and fixed over by drying at room temperature, the dry thin film of noisome suspension observed for the formation of vesicles. The photomicrograph of the preparation was also obtained from microscope by using a digital SLR camera.
Entrapment efficiency
After sonication, 1 ml of the vesicle suspension was taken in a1ml micro centrifuge tube, Centrifuged at 80,000 rpm for 1 hr at 4˚C in a cold centrifuge to get a white pellet. The supernatant was separated to determine the unentrapped amount of drug. To the pellet, 500µL of 0.1 NNaOH, was added and vortexed thoroughly for 3 min to get a white suspension. To this 5 ml of Triton X-100, was added to get a clear solution, this was further vortexed for 2 min such that to ensure that the vesiclesarelysed complete lyto release the drug [14] . The supernatant was analyzed for % drug entrapped using a Shimadzu UV spectrophotometer (Shimadzu-1700, Kyoto, Japan), at λ max of 230.4nm.
The entrapment study (EE) was calculated using the formula:
In-vitro release of adapalene niosomes
In-vitro release study of niosomes of adapalene was performed in Franz diffusion cell that has receptor compartment with an effective volume approximately 25 ml and an effective surface area of permeation of 3.14 sq cms. The egg membrane or albino rat skin was mounted between the donor and receptor compartment. The weighed amount of niosomes was placed on one side of the skin and the receptor medium was filled with phosphate buffer pH 7.4. The receptor compartment is surrounded by water jacket to maintain the temperature at 37±0.5 0 C. The heat was provided by thermostatic hot plate with a magnetic stirrer. The receptor fluid was stirred by Teflon coated magnetic bead fitted to magnetic stirrer. At each sampling interval the sample was withdrawn and was replaced by equal volume of fresh receptor fluid on each occasion.
Sample withdrawn were analyzed spectrophotometrically at 230.4 nm [15] .
Stability study of adapalene niosomes
Stability was carried out to investigate the leaching of drug from noisome suspension during storage. The all formulations were kept at refrigerated temperature (2-8 0 C), room temperature and 40 0 C (75% RH) as three different groups. Samples from each batch were withdrawn after the definite time intervals and the residual amount of drug in the vesicle was determined.
Zeta potential analysis
Zeta potential was analysed to measure the stability of noisome by studying its colloidal property. The study was conducted using zeta potential probe (MALVERN). The best formulation which has better stability was further analysed by this method for its vesicular stability.
Preparation of niosomal gel
Weighed amount of Carbopol was placed in known amount of distilled water. After complete dispersion, the polymer solution was kept in dark for 24 hours for complete swelling. The niosomal suspension was added slowly to the aqueous dispersion of polymer with the help of high speed stirrer (500 rpm) taking precaution that air did not entrap. Finally, the remaining ingredients were added to obtain a homogeneous dispersion of gel. The formed gel was then neutralized by sufficient quantity of triethanolamine. The dispersion was neutralized to pH 6 using 1% w/v NaOH solution and final weight was adjusted with distilled water. The gel was sonicated for 15mins and kept overnight to remove air bubbles [9] . (Table 2)  Table 2 : Formulation data of niosomal gel of adapalene
All quantities in percentage (%), QS-Quantity sufficient
Evaluation of niosomal gel of adapalene Clarity
The clarity of various formulations was determined by visual inspection under black and white background and it was graded as follows; turbid: +, clear: ++, very clear (glassy): +++. pH 2.5 grams of gel was accurately weighed and dispersed in 25 ml of distilled water. The pH of dispersion was measured by using digital pH meter. Akhilesh D et al.
Homogeneity
All developed gels were tested for homogeneity by visual inspection after the gels have been set in the container for their appearance and presence of any aggregate.
Spreadibility
It was determined by wooden block and glass slide apparatus. For the determination of spreadability excess of sample was applied in between two glass slides and was compressed to uniform thickness by placing 1000 gm weight for 5 minutes. Weight (50 gm) was added to pan. The time required to separate the two slides, i.e. the time in which the upper glass slide moves over the lower plates was taken as measure of Spreadability [16] . Spreadability was calculated by using the formula: 
Rheological properties
Viscosity determinations of the prepared formulations was carried out using Brookfield viscometer LVDV II spindle S18 (small sample adaptor) and the angular velocity increased from 0.1, 0.2, 0.4, 0.5, 0.8, 1.0, 1.5, 2.0, 5.0 and10.0 and measurements are noted.
Drug content
The niosomal gel of adapalene 100mg was dissolved in 50 ml of phosphate buffer 7.4 pH. The volumetric flask containing gel solution was shaken for 2 hr on mechanical shaker in order to get complete solubility of drug. This solution was filtered and estimated spectrophotometerically. The absorption was calculated at 230.8nm.
In-vitro release study of niosomal gel of adapalene
In-vitro release study of niosomal gel of adapalene was performed in Franz diffusion cell that has receptor compartment with an effective volume approximately 25 ml and an effective surface area of permeation of 3.14 sq cm. The albino rat skin was mounted between the donor and receptor compartment. The weighed amount of niosomal gel was placed on one side of the skin and the receptor medium was filled with phosphate buffer pH 7.4. The receptor compartment is surrounded by water jacket to maintain the temperature at 37 0.5 0 C. The heat was provided by thermostatic hot plate with a magnetic stirrer. The receptor fluid was stirred by Teflon coated magnetic bead fitted to magnetic stirrer. At each sampling interval the sample was withdrawn and was replaced by equal volume of fresh receptor fluid on each occasion. Sample withdrawn were analyzed spectrophotometrically at 230.8 nm.
Kinetic data analysis
The release kinetics was evaluated considering four different models including Zero order, Higuchi's equation and Korsmeyer-Peppa's equation and the selection was based on the comparison of relevant correlation coefficients and linearity test [17, 18] .
Anova test
The ANOVA test was carried out using the standard deviation of total % CDR and drug content of each formulation and "P" value was calculated to determine the significance. The anova test was carried out by using tukey-kramer multiple comparison test method
Skin irritation test
The hair on the dorsal side of albino rats was removed by clipping 1 day before this portion of the experiment. The rabbits were divided into 3 groups. Group I served as the control, group II received niosomal gel of adapalene, group III received marketed gel of adapalene, and group IV received a 0.8% v/v aqueous solution of formalin as a standard irritant. A new gel, or new formalin solution, was applied daily for 7 days. Finally, the application sites were graded according to visual scoring scale. The skin irritation test was performed on white rat, by applying 1gm gel formulation on 9 cm 2 areas. An aqueous solution of 1ml, containing 0.8% formalin soaked in 9 cm 2 cotton wool (standard irritant) was placed in the back of the rabbit. The cotton wool was secured firmly in the back of the rat. The cotton wool was secured firmly in the place with adhesive plaster. The animal was observed for 7 days for any sign of edema and erythema [16] .
Results and Discussion
Preformulation study
The colour and odour of the drug were characterized and recorded using descriptive terminology. It was found as White to Jasmine Crystalline Powder and which was found to be odourless. The calibration curve was prepared after the determination of absorption maxima. The absorption maxima were found to be 230.8nm. The slope of the curve was found to be 0.0924. The infrared spectra of adapalene as well as its formulation were taken which showed characteristic stretch between 3500-3200 cm -1 (O-H stretch in acid), stretch between 1760-1665 cm -1 (C=O stretch in acid) and the strong absorption bands are seen between 900-650cm -1 indicates presence of aromatic groups. There were no changes in the major peaks of adapalene in the Wavenumber [cm-1] Fig 1(a) : FTIR spectrum of pure adapalene.
Wavenumber [cm-1] Figure 1(c): FTIR spectrum of cholesterol
Optical microscopy and Vesicular Size determination
The niosomes prepared using adapalene drug was studied under 400x magnifications to observe the formation of niosomal vesicles. The niosomal vesicles were found to be uniform in size and shape. The sizes of particles were determined by optical microscopy and the particles revealed unilamellar vesicles with no agglomeration. The mean particle size was found to be 3.89±0.78 to 4.95±1.23 which is an ideal size. 
Entrapment efficiency
The entrapment efficiency was studied for all the 7 formulation to find the best, in terms of entrapment efficiency. The entrapment efficiency was found to be higher in the formulation no. F5 (58.67±0.22%), which may have optimum surfactant cholesterol ratio to provide higher entrapment of adapalene in niosomal vesicles. Very low cholesterol content in formulation F7 caused the lowest entrapment efficiency (47.32±0.49) may be due leakage of vesicles. (Table 3) 
In-vitro release of adapalene niosomes
The in-vitro release of the all the prepared niosomal formulation was carried out using the Franz diffusion cell. The formulation F5 showed the highest cumulative drug release after the period of 3 hours. The all the formulations showed similar type of release over a period of 3 hours. The F7 showed the least release may be due to the lower entrapment. (Figure 3) 
Stability study
The stability study was carried out for all the niosomal formulation over a period of 2 months. The entrapment efficiency was measured to compare the stability of the samples. The one set of samples were under refrigerator at 4-8 0 C for two months and other sets of samples were kept at 25±2 0 C for two months and the entrapment efficiency of all the samples were measured and compared with fresh sample after 2 months. The all samples were found to stable without much difference in entrapment efficiency.
Zeta potential
The zeta potential was found to be (28.0 mV) after analysing the best formulation F5 form MALVERN ZETA POTENTIAL analyser. The avg. Size of particles was (558.6nm) and Pdi value was 0.489. 
Evaluation of niosomal gel of adapalene
The best niosomal formulation of adapalene was used to prepare topical gel. F5 was taken as the best formulation. The gel was evaluated clarity, pH, homogeneity, and spread ability. The all formulations were found to be clear, pH was in range between (6.2-6.7), the formulations were homogenous and spread ability was in range (18-20g .cm/sec). The viscosity was in range of (9632-18693cps). The viscosity of marketed gel was found to be 9863cps. (Table 4) The in-vitro release study of niosomal gel of adapalene was carried out using the Franz diffusion cell. The rat abdominal skin was used as membrane. The formulation F5b showed the maximum release after the period of 3 hours. The release was compared with marketed product and was better than marketed product (Figure 4 ).
Figure 4: In-vitro release study of adapalene gelniosomes
Following the seven days of application of the gel the results of skin irritation test were tabulated in Table 5 . The results indicated that the control preparation (which did not contain any drug), the test niosomal gel of adapalene and marketed gel did not cause any skin irritation or reaction. It can be assured that the adapalene niosomes and the excipients did not cause any skin irritation and can be used as gel formulation. (Figure 5 a-d) The skin irritation test on rat showed no particular reaction or irritation by application of test sample and marketed product. The formulation F5b showed no irritation or reaction on the skin. This study was conducted in accordance with CPCSEA guidelines and experimental protocol was approved by approved by Institutional Animal Ethics Committee. The mechanism and kinetics of drug release of adapalene was determined by the application of Korsmeyer-Peppa's model, Higuchi's model and Zero order model. From the release kinetics of all the formulations, it was found that zero order kinetics, Higuchi model and KorsmeyerPeppa's model were best fitted for the niosomal gel of adapalene. The correlation coefficient (r) was used as an indicator for the best fitting for each of the models considered. The release pattern of all developed formulation followed Zero order kinetics, Higuchi model and Korsmeyer-Peppa's model. The mechanism of drug release was followed super case ІІ transport with "n" values greater than 1 in Korsmeyer-Peppa's model. This indicates the drug release depends on swelling and diffusion mechanism of release. (Table 6) Physical stability of niosomal gel formulations were studied for a period of 90 days. The samples were determined for all formulations stored at 4-8 0 C and 25±2 0 C. All the samples were tested for drug content. (Table 7) The anova test was carried out between the formulations considering the % CDR values. The "P" values were found to be extremely significant. The P value was less than 0.001.The anova was also carried out between the formulations considering the drug content. The "P" values of formulation F5b, F5c, F5d and F5e were found to be extremely significant to Mkt gel with the P value less than 0.001. The "P" value of formulation F5a was found moderately significant to Mkt gel with P value less than 0.01. Data are represented as mean ± SD (n= 2)
Conclusion
Adapalene a hydrophobic drug can be better entrapped in the cholesterol surfactant multilamellar vesicles by lipid film hydration method and the study will help to enhance the action of the drug. Lipid film hydration method is the best method of preparing multilamellar vesicles as it is important in the case of hydrophobic drug. Adapalene was successfully entrapped within the vesicular system with high efficiency showed all the physical characteristics within acceptable limits with significant in vitro release pattern and good stability also. The formulation having the best characteristic was selected to fabricate the transdermal gel using carbopol 934. The niosomal gel showed good physical properties and optimum drug release pattern. The kinetic data analysis revealed that the formulated gel follows Zero order release kinetics. The Higuchi's plot for the formulation indicated that the predominant mechanism of drug release is diffusion and the data were fitted according to the Korsmeyer-Peppa's model indicated that the drug permeation from the niosomal gel followed diffusion and super case ІІ transport. The ANOVA test was carried out and values were extremely significant values with P≤0.001 compared for % CDR with marketed gel. Also the values were significant with marketed gel when compared the drug content of formulation with marketed formulation. The above results lead us to the conclusion that the niosomal gels can be a promising carrier for adapalene.
